As of 2025-12-18, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (0.39) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -1663.0%.
The range of the Relative Valuation is (0.39) - (0.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 18.6x | 16.6x |
| Forward P/E multiples | 17.1x - 18.2x | 17.6x |
| Fair Price | (0.39) - (0.41) | (0.39) |
| Upside | -1658.4% - -1758.7% | -1663.0% |
| Date | P/E |
| 2025-12-12 | -1.10 |
| 2025-12-11 | -0.88 |
| 2025-12-10 | -1.10 |
| 2025-12-09 | -1.10 |
| 2025-12-08 | -1.32 |
| 2025-12-05 | -1.10 |
| 2025-12-04 | -1.10 |
| 2025-12-02 | -1.10 |
| 2025-12-01 | -1.10 |
| 2025-11-28 | -1.10 |
| 2025-11-27 | -1.10 |
| 2025-11-26 | -0.88 |
| 2025-11-25 | -1.10 |
| 2025-11-24 | -1.10 |
| 2025-11-20 | -1.10 |
| 2025-11-19 | -0.88 |
| 2025-11-18 | -1.10 |
| 2025-11-17 | -0.88 |
| 2025-11-14 | -1.10 |
| 2025-11-13 | -1.10 |
| 2025-11-12 | -1.10 |
| 2025-11-11 | -0.88 |
| 2025-11-06 | -1.10 |
| 2025-11-05 | -1.10 |
| 2025-11-04 | -1.10 |
| 2025-11-03 | -1.10 |
| 2025-10-31 | -1.10 |
| 2025-10-30 | -1.32 |
| 2025-10-29 | -1.32 |
| 2025-10-28 | -1.32 |
| 2025-10-27 | -1.32 |
| 2025-10-24 | -1.32 |
| 2025-10-23 | -1.32 |
| 2025-10-22 | -1.32 |
| 2025-10-21 | -1.32 |
| 2025-10-20 | -1.32 |
| 2025-10-17 | -1.32 |
| 2025-10-16 | -1.32 |
| 2025-10-15 | -1.10 |
| 2025-10-14 | -1.10 |
| 2025-10-10 | -1.10 |
| 2025-10-09 | -1.32 |
| 2025-10-08 | -1.10 |
| 2025-10-07 | -1.32 |
| 2025-10-06 | -1.32 |
| 2025-10-03 | -1.32 |
| 2025-10-02 | -1.54 |
| 2025-10-01 | -1.76 |
| 2025-09-30 | -0.66 |
| 2025-09-29 | -0.66 |